                         SEQUENCE LISTING

<110>  F. Hoffmann-La Roche AG
 
<120>  AR-V7 INHIBITORS

<130>  P33817-WO

<150>  16205150.2
<151>  2016-12-19

<160>  9     

<170>  PatentIn version 3.5

<210>  1
<211>  38
<212>  DNA
<213>  Artificial sequence

<220>
<223>  hARWT template 1 DNA

<400>  1
catcatcatc atcatcatgg tacctgcctg atctgtgg                               38


<210>  2
<211>  41
<212>  DNA
<213>  Artificial sequence

<220>
<223>  hARWT template 2 DNA

<400>  2
caggctgaaa atcttctctc agtgtccagc acacactaca c                           41


<210>  3
<211>  42
<212>  DNA
<213>  Artificial sequence

<220>
<223>  pTrc 1

<400>  3
atctccacag atcaggcagg taccatgatg atgatgatga tg                          42


<210>  4
<211>  42
<212>  DNA
<213>  Artificial sequence

<220>
<223>  pTrc 2

<400>  4
ggtgtagtgt gtgctggaca ctgagagaag attttcagcc tg                          42


<210>  5
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  5

Gly Leu Asn Asp Ile Phe Glu Ala Gln Lys Ile Glu Trp His Glu 
1               5                   10                  15  


<210>  6
<211>  42
<212>  DNA
<213>  Artificial sequence

<220>
<223>  pcDNA3.1 AR-V7 template 1 DNA

<400>  6
ggtgctggag caggtgctgg aatggaagtg cagttagggc tg                          42


<210>  7
<211>  42
<212>  DNA
<213>  Artificial sequence

<220>
<223>  pcDNA3.1 AR-V7 template DNA

<400>  7
ggaaataggg tttccaatgc ttcagggtct ggtcattttg ag                          42


<210>  8
<211>  38
<212>  DNA
<213>  Artificial sequence

<220>
<223>  pEYFPC1 vector 1 DNA

<400>  8
cagccctaac tgcacttcca ttccagcacc tgctccag                               38


<210>  9
<211>  42
<212>  DNA
<213>  Artificial sequence

<220>
<223>  pEYFPC1 vector 2 DNA

<400>  9
ctcaaaatga ccagaccctg aagcattgga aaccctattt cc                          42


